Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMATE.L Regulatory News (MATE)

  • There is currently no data for MATE

Annual overview from QuotedData

3 May 2023 17:17

RNS Number : 3285Y
JPMorgan Multi-Asset Grwth & Income
03 May 2023
 

JPMorgan Multi-Asset Growth & Income - Annual overview from QuotedData

3rd May 2023

Caution in the face of volatile markets

In a world of volatile equity markets and uncertain futures, MATE offers investors a refreshingly straightforward target of achieving an average of 6% compound annual returns over a rolling five-year period and paying an inflation-linked dividend.

MATE has now passed its five-year anniversary, and its life has been marked by two of the worst bear markets in recent memory. Given that we are in the grip of a painful downturn, it is unsurprising that MATE has fallen short of its target return. Commendably, the team has not taken on more risk in an attempt to catch up. As evidence of this, the standard deviation of MATE's net asset value (NAV) returns over the past five years is half that of the global equity market.

MATE's commitment to providing an attractive and growing income, is supported by its revised dividend policy. Its combination of target long-term returns and attractive income remains its defining feature, and one which sets it apart from its peers. MATE has also been able to sustain a narrow discount throughout 2022, and its shares currently trade on 3.3% discount to NAV.

Full Research:

https://quoteddata.com/research/jpmorgan-multiasset-growth-income-caution-face-volatile-markets-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on JPMorgan Multi-Asset Growth & Income Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUOANROVUVRAR
Date   Source Headline
25th Oct 202311:12 amRNSNet Asset Value(s)
24th Oct 202311:01 amRNSNet Asset Value(s)
23rd Oct 202311:45 amRNSGearing announcement
23rd Oct 202311:20 amRNSNet Asset Value(s)
20th Oct 20235:08 pmRNSTransaction in Own Shares
20th Oct 20231:52 pmRNSNet Asset Value(s)
19th Oct 202310:52 amRNSNet Asset Value(s)
18th Oct 202311:02 amRNSNet Asset Value(s)
17th Oct 202311:15 amRNSNet Asset Value(s)
16th Oct 202312:45 pmRNSGearing announcement
16th Oct 202310:50 amRNSNet Asset Value(s)
13th Oct 202311:27 amRNSNet Asset Value(s)
12th Oct 20234:14 pmRNSHalf Year Results
12th Oct 20234:10 pmRNSTen Largest Investments
12th Oct 202311:14 amRNSNet Asset Value(s)
11th Oct 202311:04 amRNSNet Asset Value(s)
10th Oct 202311:37 amRNSNet Asset Value(s)
9th Oct 20235:24 pmRNSTransaction in Own Shares
9th Oct 202312:50 pmRNSGearing Announcement
9th Oct 202311:16 amRNSNet Asset Value(s)
6th Oct 202311:43 amRNSNet Asset Value(s)
5th Oct 202310:56 amRNSNet Asset Value(s)
4th Oct 202311:44 amRNSNet Asset Value(s)
3rd Oct 202311:25 amRNSNet Asset Value(s)
2nd Oct 20231:21 pmRNSGearing Announcement
2nd Oct 202312:45 pmRNSNet Asset Value(s)
2nd Oct 202311:23 amRNSTotal Voting Rights
28th Sep 202311:30 amRNSNet Asset Value(s)
27th Sep 202310:56 amRNSNet Asset Value(s)
26th Sep 202311:05 amRNSNet Asset Value(s)
25th Sep 202312:37 pmRNSGearing Announcement
25th Sep 202312:07 pmRNSNet Asset Value(s)
22nd Sep 202311:04 amRNSNet Asset Value(s)
21st Sep 20234:58 pmRNSTransaction in Own Shares
21st Sep 202311:31 amRNSDividend Declaration
21st Sep 202311:15 amRNSNet Asset Value(s)
20th Sep 202310:38 amRNSNet Asset Value(s)
19th Sep 202310:36 amRNSNet Asset Value(s)
18th Sep 202312:53 pmRNSGearing Announcement
18th Sep 202311:07 amRNSNet Asset Value(s)
15th Sep 202311:32 amRNSNet Asset Value(s)
14th Sep 20234:56 pmRNSTransaction in Own Shares
14th Sep 202311:08 amRNSNet Asset Value(s)
13th Sep 202311:50 amRNSTen Largest Investments
13th Sep 202310:59 amRNSNet Asset Value(s)
12th Sep 202310:58 amRNSNet Asset Value(s)
11th Sep 202312:56 pmRNSGearing Announcement
11th Sep 202310:58 amRNSNet Asset Value(s)
8th Sep 202311:11 amRNSNet Asset Value(s)
7th Sep 202310:53 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.